{"id":"https://openalex.org/W4282983147","doi":"https://doi.org/10.1158/1538-7445.am2022-6225","title":"Abstract 6225: Developing a novel combination therapy using engineered chimeric antigen receptor natural killer cells targeting avsialidase with avsialidase-armed oncolytic vaccinia virus in solid tumor models","display_name":"Abstract 6225: Developing a novel combination therapy using engineered chimeric antigen receptor natural killer cells targeting avsialidase with avsialidase-armed oncolytic vaccinia virus in solid tumor models","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282983147","doi":"https://doi.org/10.1158/1538-7445.am2022-6225"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-6225","doi":"https://doi.org/10.1158/1538-7445.am2022-6225","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-6225","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100457078","display_name":"Xiaomei Wang","orcid":"https://orcid.org/0000-0001-7411-9184","observed_orcids":["https://orcid.org/0000-0001-7411-9184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaomei Wang","raw_affiliation_strings":["1Ansun Biopharma, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ansun Biopharma, Houston, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Guowei Wei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150458","display_name":"Ansun BioPharma (United States)","ror":"https://ror.org/04vwk8m55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150458"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guowei Wei","raw_affiliation_strings":["2Ansun Biopharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ansun Biopharma, San Diego, CA","institution_ids":["https://openalex.org/I4210150458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057431052","display_name":"Keshav B. Karki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keshav B. Karki","raw_affiliation_strings":["1Ansun Biopharma, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ansun Biopharma, Houston, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Winnie Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150458","display_name":"Ansun BioPharma (United States)","ror":"https://ror.org/04vwk8m55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150458"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Winnie Chan","raw_affiliation_strings":["2Ansun Biopharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ansun Biopharma, San Diego, CA","institution_ids":["https://openalex.org/I4210150458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008293672","display_name":"Mariya Viskovska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariya Viskovska","raw_affiliation_strings":["1Ansun Biopharma, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ansun Biopharma, Houston, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew Williams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Williams","raw_affiliation_strings":["1Ansun Biopharma, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ansun Biopharma, Houston, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nancy Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nancy Chang","raw_affiliation_strings":["1Ansun Biopharma, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ansun Biopharma, Houston, TX;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068398472","display_name":"Haiyan Jiang","orcid":"https://orcid.org/0000-0002-5778-4008","observed_orcids":["https://orcid.org/0000-0002-5778-4008"]},"institutions":[{"id":"https://openalex.org/I4210150458","display_name":"Ansun BioPharma (United States)","ror":"https://ror.org/04vwk8m55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150458"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haiyan Jiang","raw_affiliation_strings":["2Ansun Biopharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ansun Biopharma, San Diego, CA","institution_ids":["https://openalex.org/I4210150458"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"6225","last_page":"6225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.5922999978065491,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.5922999978065491,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.17239999771118164,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.16200000047683716,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-vaccinia-virus","display_name":"oncolytic vaccinia virus","score":0.8479999899864197},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6679999828338623},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5569999814033508},{"id":"https://openalex.org/keywords/il-15","display_name":"IL-15","score":0.6800000071525574},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6399999856948853},{"id":"https://openalex.org/keywords/adoptive-nk-cell-therapy","display_name":"adoptive NK cell therapy","score":0.6309999823570251},{"id":"https://openalex.org/keywords/actinomyces-viscosus","display_name":"Actinomyces viscosus","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.7459337115287781},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.7329596877098083},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5521180629730225},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.52692711353302},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46533647179603577},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4357394874095917},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.4354126453399658},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4306107461452484},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.42025333642959595},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4182320535182953},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.41567185521125793},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4058382511138916},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3999054729938507},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1135457456111908},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-6225","doi":"https://doi.org/10.1158/1538-7445.am2022-6225","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-6225","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3081669695","https://openalex.org/W3016228284","https://openalex.org/W4391888119","https://openalex.org/W4282932682","https://openalex.org/W7223474837","https://openalex.org/W4388534883","https://openalex.org/W4282974095","https://openalex.org/W4385754512","https://openalex.org/W3129095325","https://openalex.org/W4409909579"],"abstract_inverted_index":{"Abstract":[0],"Chimeric":[1],"antigen":[2,52,177,412],"receptor":[3,413],"(CAR)":[4],"-":[5],"engineered":[6,410],"natural":[7,414],"killer":[8,415],"(NK)":[9],"cell":[10,78,83,259,306],"therapy":[11,27,84,408],"has":[12,30],"emerged":[13],"as":[14,159],"a":[15,61,69,107,160,405],"promising":[16],"platform":[17],"for":[18,21,163,170,203,209,380,435],"adoptive":[19],"immunotherapy":[20],"cancer.":[22],"However,":[23],"CAR-NK":[24,82],"or":[25,322,342],"CAR-T":[26],"so":[28],"far":[29],"achieved":[31],"limited":[32],"efficacy":[33,372],"in":[34,54,94,196,226,295,375,424],"solid":[35,55,383,425],"tumors":[36],"compared":[37],"with":[38,81,167,274,377,419],"hematologic":[39],"malignancies.":[40],"One":[41],"of":[42,48,106,124,136,218,382,431],"the":[43,46,90,104,116,134,148,313,349,432],"challenges":[44],"is":[45],"lack":[47],"prevalent":[49],"tumor-specific":[50],"surface":[51,149],"target":[53,162,257],"tumors.":[56,384],"Hence,":[57],"we":[58,120,355],"are":[59],"developing":[60],"novel":[62,406],"oncolytic":[63,421],"vaccinia":[64,91,422],"virus":[65,92,423],"(VV)":[66],"to":[67,85,102,172,221,242,369],"deliver":[68],"dual":[70],"functional":[71],"glycol-immune":[72],"checkpoint":[73],"inhibitor":[74],"and":[75,98,127,141,176,205,213,245,263,268,278,373],"universal":[76,161],"tumor":[77,129,154,258,293,305,314,333,350,426],"marker":[79],"combined":[80],"increase":[86],"anti-tumor":[87],"efficacy.":[88],"Using":[89],"deleted":[93],"both":[95,125],"viral":[96,117],"TK":[97],"VGF":[99],"genes":[100],"(vvDD)":[101],"drive":[103],"expression":[105],"membrane-bound":[108],"sialidase":[109,267,337],"derived":[110,249],"from":[111,250],"actinomyces":[112],"viscosus":[113],"(avSial)":[114],"under":[115],"late":[118],"promoter,":[119],"observed":[121],"efficient":[122],"desialylation":[123],"VV-infected":[126,153],"non-infected":[128],"cells,":[130,166,283],"which":[131],"would":[132],"alleviate":[133],"suppression":[135],"sialic":[137],"acid":[138],"on":[139,152],"NK":[140,165,211,247,277,282,286,310,321,324,329,341,344,364],"other":[142],"immune":[143],"cells":[144,155,248,294,345,416],"within":[145],"TME.":[146],"Further,":[147],"bound":[150],"avSial":[151,284,308,327,360],"can":[156],"also":[157,271,311],"serve":[158],"avSial-CAR":[164],"less":[168],"concern":[169],"cross-reactivity":[171],"normal":[173],"human":[174,206],"tissues":[175],"loss.":[178],"We":[179],"developed":[180,357],"anti-avSial":[181,219,233],"antibodies":[182],"through":[183],"mice":[184],"immunization":[185],"study.":[186],"The":[187,215,231],"selected":[188,232],"single":[189],"chain":[190],"variable":[191],"fragments":[192],"(scFV)":[193],"were":[194,223,236,270],"constructed":[195],"CAR":[197,227,235,276,285,309,320,328,340,362],"format":[198],"containing":[199],"CD28":[200],"CD3":[201],"\u03b6":[202],"co-stimulation":[204],"IL-15":[207],"gene":[208],"better":[210,317],"persistence":[212],"function.":[214],"binding":[216],"affinity":[217],"scFv":[220,234],"avSialidase":[222],"further":[224],"screened":[225],"constructs-transfected":[228],"293T":[229],"cells.":[230,325],"packaged":[237],"into":[238],"gamma":[239],"retroviral":[240],"vectors":[241],"transduce":[243],"activated":[244],"expanded":[246],"healthy":[251],"donor":[252],"peripheral":[253],"blood.":[254],"For":[255],"proof-of-concept,":[256],"lines":[260],"A375,":[261],"A549":[262],"HT-29":[264],"expressing":[265,335],"transmembrane":[266,336],"GFP":[269],"generated.":[272],"Compared":[273],"CD19":[275,319,339],"none":[279],"transduced":[280],"(NT)":[281],"had":[287],"markedly":[288],"increased":[289],"cytotoxicity":[290],"against":[291],"avSial-expressing":[292],"co-culture":[296],"assays":[297],"at":[298],"low":[299],"E:T":[300],"ratios":[301],"<=":[302],"1:2.":[303],"Upon":[304],"rechallenge,":[307],"controlled":[312,348],"growth":[315],"significantly":[316],"than":[318],"NT":[323,343],"Furthermore,":[326],"completely":[330],"eliminated":[331],"A375":[332],"spheroids":[334,351],"whereas":[338],"only":[346],"transiently":[347],"growth.":[352],"Taken":[353],"together,":[354],"have":[356],"an":[358],"effective":[359],"targeting":[361,417],"IL15":[363],"that":[365],"will":[366],"be":[367],"used":[368],"demonstrate":[370],"enhanced":[371],"versatility":[374],"combination":[376,407],"avSial-armed":[378],"VV":[379],"treatment":[381],"Citation":[385],"Format:":[386],"Xiaomei":[387],"Wang,":[388],"Guowei":[389],"Wei,":[390],"Keshav":[391],"B.":[392],"Karki,":[393],"Winnie":[394],"Chan,":[395],"Mariya":[396],"Viskovska,":[397],"Andrew":[398],"Williams,":[399],"Nancy":[400],"Chang,":[401],"Haiyan":[402],"Jiang.":[403],"Developing":[404],"using":[409],"chimeric":[411],"avsialidase":[418],"avsialidase-armed":[420],"models":[427],"[abstract].":[428],"In:":[429],"Proceedings":[430],"American":[433],"Association":[434],"Cancer":[436,447],"Research":[437],"Annual":[438],"Meeting":[439],"2022;":[440],"2022":[441],"Apr":[442],"8-13.":[443],"Philadelphia":[444],"(PA):":[445],"AACR;":[446],"Res":[448],"2022;82(12_Suppl):Abstract":[449],"nr":[450],"6225.":[451]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-06-17T00:00:00"}